PCRX

Pacira BioSciences, Inc.

29.36 USD
+0.71 (+2.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pacira BioSciences, Inc. stock is down -1.11% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 13 June’s closed higher than May. In the last 4 Unusual Options Trades, there were 2 CALLs, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 May 17:47 16 Aug, 2024 35.00 CALL 400 37
08 May 18:30 21 Jun, 2024 30.00 CALL 500 16
13 May 19:52 16 Aug, 2024 30.00 PUT 144 0
11 Jun 15:24 16 Aug, 2024 25.00 PUT 1000 4352

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectionable suspension. iovera system produces controlled doses of cold temperature only to targeted nerves.